|Day Low/High||118.26 / 122.11|
|52 Wk Low/High||113.52 / 165.66|
Here is the updated list of drugs facing FDA approval decisions.
Strategic Hotels & Resorts was one of several companies to announce public offerings.
Jazz Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript
News of a drug's approval or rejection from the FDA can rock or kill a biotech stock's price. Here are 14 companies with drugs facing FDA approval decisions in 2010.
Jazz Pharmaceuticals' 3rd-quarter loss narrows on sales of sleep disorder drug Xyrem
Uncertainty over Zevalin's relaunch likely weighing on stock price
Negative results announced from two phase III studies in graft-versus-host-disease
Classic technical analysis teaches that price and volume are interconnected, but this relationship has become unreliable in recent years.
Fidelity's Advisor Biotechnology fund topped the mutual-fund rankings, catapulted by a quadrupling in the share price of Jazz Pharmaceuticals.
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
Part 3 in our quick-and-dirty guide to upcoming clinical trial dates for drug and biotech companies.
BofA, Boeing, Alcoa, Jazz Pharma, Cavalier Homes are among big market movers Monday
Jazz Pharmaceuticals reports positive results for late-stage study on pain-condition drug
The wrinkle-treatment device maker soars after saying it had received an offer from a third party.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.